Literature DB >> 35245086

Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.

Fábio F Rosa1,2,3,4, Cristiana F Pires1,2,3, Ilia Kurochkin1,2,5, Evelyn Halitzki1,2, Tasnim Zahan1,2, Nejc Arh1,2, Olga Zimmermannová1,2, Alexandra G Ferreira1,2,3,4, Hongzhe Li6, Stefan Karlsson1, Stefan Scheding6,7, Carlos-Filipe Pereira1,2,3.   

Abstract

Type 1 conventional dendritic cells (cDC1s) are rare immune cells critical for the induction of antigen-specific cytotoxic CD8+ T cells, although the genetic program driving human cDC1 specification remains largely unexplored. We previously identified PU.1, IRF8, and BATF3 transcription factors as sufficient to induce cDC1 fate in mouse fibroblasts, but reprogramming of human somatic cells was limited by low efficiency. Here, we investigated single-cell transcriptional dynamics during human cDC1 reprogramming. Human induced cDC1s (hiDC1s) generated from embryonic fibroblasts gradually acquired a global cDC1 transcriptional profile and expressed antigen presentation signatures, whereas other DC subsets were not induced at the single-cell level during the reprogramming process. We extracted gene modules associated with successful reprogramming and identified inflammatory signaling and the cDC1-inducing transcription factor network as key drivers of the process. Combining IFN-γ, IFN-β, and TNF-α with constitutive expression of cDC1-inducing transcription factors led to improvement of reprogramming efficiency by 190-fold. hiDC1s engulfed dead cells, secreted inflammatory cytokines, and performed antigen cross-presentation, key cDC1 functions. This approach allowed efficient hiDC1 generation from adult fibroblasts and mesenchymal stromal cells. Mechanistically, PU.1 showed dominant and independent chromatin targeting at early phases of reprogramming, recruiting IRF8 and BATF3 to shared binding sites. The cooperative binding at open enhancers and promoters led to silencing of fibroblast genes and activation of a cDC1 program. These findings provide mechanistic insights into human cDC1 specification and reprogramming and represent a platform for generating patient-tailored cDC1s, a long-sought DC subset for vaccination strategies in cancer immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35245086      PMCID: PMC7613284          DOI: 10.1126/sciimmunol.abg5539

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  48 in total

1.  Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.

Authors:  Miranda L Broz; Mikhail Binnewies; Bijan Boldajipour; Amanda E Nelson; Joshua L Pollack; David J Erle; Andrea Barczak; Michael D Rosenblum; Adil Daud; Diane L Barber; Sebastian Amigorena; Laura J Van't Veer; Anne I Sperling; Denise M Wolf; Matthew F Krummel
Journal:  Cancer Cell       Date:  2014-10-16       Impact factor: 31.743

2.  Mapping the human DC lineage through the integration of high-dimensional techniques.

Authors:  Peter See; Charles-Antoine Dutertre; Jinmiao Chen; Patrick Günther; Naomi McGovern; Sergio Erdal Irac; Merry Gunawan; Marc Beyer; Kristian Händler; Kaibo Duan; Hermi Rizal Bin Sumatoh; Nicolas Ruffin; Mabel Jouve; Ester Gea-Mallorquí; Raoul C M Hennekam; Tony Lim; Chan Chung Yip; Ming Wen; Benoit Malleret; Ivy Low; Nurhidaya Binte Shadan; Charlene Foong Shu Fen; Alicia Tay; Josephine Lum; Francesca Zolezzi; Anis Larbi; Michael Poidinger; Jerry K Y Chan; Qingfeng Chen; Laurent Rénia; Muzlifah Haniffa; Philippe Benaroch; Andreas Schlitzer; Joachim L Schultze; Evan W Newell; Florent Ginhoux
Journal:  Science       Date:  2017-05-04       Impact factor: 47.728

3.  Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.

Authors:  Lionel Franz Poulin; Mariolina Salio; Emmanuel Griessinger; Fernando Anjos-Afonso; Ligia Craciun; Ji-Li Chen; Anna M Keller; Olivier Joffre; Santiago Zelenay; Emma Nye; Alain Le Moine; Florence Faure; Vincent Donckier; David Sancho; Vincenzo Cerundolo; Dominique Bonnet; Caetano Reis e Sousa
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

4.  Dendritic Cells Revisited.

Authors:  Mar Cabeza-Cabrerizo; Ana Cardoso; Carlos M Minutti; Mariana Pereira da Costa; Caetano Reis e Sousa
Journal:  Annu Rev Immunol       Date:  2021-01-22       Impact factor: 28.527

5.  Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells.

Authors:  Margaret E Kirkling; Urszula Cytlak; Colleen M Lau; Kanako L Lewis; Anastasia Resteu; Alireza Khodadadi-Jamayran; Christian W Siebel; Hélène Salmon; Miriam Merad; Aristotelis Tsirigos; Matthew Collin; Venetia Bigley; Boris Reizis
Journal:  Cell Rep       Date:  2018-06-19       Impact factor: 9.423

Review 6.  Understanding and Modulating Immunity With Cell Reprogramming.

Authors:  Cristiana F Pires; Fábio F Rosa; Ilia Kurochkin; Carlos-Filipe Pereira
Journal:  Front Immunol       Date:  2019-12-11       Impact factor: 7.561

7.  A transient disruption of fibroblastic transcriptional regulatory network facilitates trans-differentiation.

Authors:  Yasuhiro Tomaru; Ryota Hasegawa; Takahiro Suzuki; Taiji Sato; Atsutaka Kubosaki; Masanori Suzuki; Hideya Kawaji; Alistair R R Forrest; Yoshihide Hayashizaki; Jay W Shin; Harukazu Suzuki
Journal:  Nucleic Acids Res       Date:  2014-07-10       Impact factor: 16.971

8.  Batf Pioneers the Reorganization of Chromatin in Developing Effector T Cells via Ets1-Dependent Recruitment of Ctcf.

Authors:  Duy Pham; Carson E Moseley; Min Gao; Daniel Savic; Colleen J Winstead; Mengxi Sun; Barbara L Kee; Richard M Myers; Casey T Weaver; Robin D Hatton
Journal:  Cell Rep       Date:  2019-10-29       Impact factor: 9.423

9.  Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1.

Authors:  Julia Minderjahn; Andreas Schmidt; Andreas Fuchs; Rudolf Schill; Johanna Raithel; Magda Babina; Christian Schmidl; Claudia Gebhard; Sandra Schmidhofer; Karina Mendes; Anna Ratermann; Dagmar Glatz; Margit Nützel; Matthias Edinger; Petra Hoffmann; Rainer Spang; Gernot Längst; Axel Imhof; Michael Rehli
Journal:  Nat Commun       Date:  2020-01-21       Impact factor: 14.919

Review 10.  Cell Fate Reprogramming in the Era of Cancer Immunotherapy.

Authors:  Olga Zimmermannova; Inês Caiado; Alexandra G Ferreira; Carlos-Filipe Pereira
Journal:  Front Immunol       Date:  2021-07-21       Impact factor: 7.561

View more
  1 in total

Review 1.  Epigenetics, Enhancer Function and 3D Chromatin Organization in Reprogramming to Pluripotency.

Authors:  Andreas Hörnblad; Silvia Remeseiro
Journal:  Cells       Date:  2022-04-21       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.